(Q34149651)

31 July 2017

Factors affecting transmission of mucosal human papillomavirus (English)

1 reference

31 July 2017

Nienke J Veldhuijzen

1

1 reference

31 July 2017

Peter Jf Snijders

2

1 reference

31 July 2017

Peter Reiss

3

1 reference

31 July 2017

Chris Jlm Meijer

4

1 reference

31 July 2017

Janneke Hhm van de Wijgert

5

1 reference

31 July 2017

11 November 2010

1 reference

Lancet Infectious Diseases

31 July 2017

1 reference

31 July 2017

10

1 reference

31 July 2017

12

1 reference

31 July 2017

862-874

1 reference

Classification of papillomaviruses

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

The papillomavirus life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Impact of HPV infection in adolescent populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Immune responses to human papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Clinician's guide to human papillomavirus immunology: knowns and unknowns

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Correlating immunity with protection for HPV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

High-risk HPV type-specific clearance rates in cervical screening

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Self-collection of genital human papillomavirus specimens in heterosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus infections among couples in new sexual relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Incidence of and risk factors for genital human papillomavirus infection in women drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Risk of female human papillomavirus acquisition associated with first male sex partner

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Incidence and outcome of acquisition of human papillomavirus infection in women with normal cytology--a population-based cohort study from Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Highly effective contraception and acquisition of HIV and other sexually transmitted infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Determinants of Prevalence, Acquisition, and Persistence of Human Papillomavirus in Healthy Mexican Military Men

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Chapter 6: Epidemiology and transmission dynamics of genital HPV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

HPV-associated flat penile lesions in men of a non-STD hospital population: less frequent and smaller in size than in male sexual partners of women with CIN.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus infections of the genital and respiratory tracts in young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Seroprevalence of human papillomavirus type 16 in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

High risk genital papillomavirus infections are spread vertically

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papilloma virus (HPV) infection in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papilloma virus infection prior to coitarche

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus infections in children: the potential role of maternal transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Condom use and the risk of genital human papillomavirus infection in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Prevalence of HPV infection among men: A systematic review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Measuring sexual behaviour: methodological challenges in survey research.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Host and viral genetics and risk of cervical cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: preliminary data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus infection in women infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus types among women infected with HIV: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Epidemiology of human papillomavirus infection among fishermen along Lake Victoria Shore in the Kisumu District, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus-related disease in people with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Highly active antiretroviral therapy and cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Cervical cancer and use of hormonal contraceptives: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus infection and use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus prevalence at the USA-Mexico border among women 40 years of age and older.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Effects of cigarette smoke on the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Chlamydia trachomatis infection and persistence of human papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Viral sexually transmitted infections and bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Increased frequency of bacterial vaginosis and Chlamydia trachomatis in pregnant women with human papillomavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Association between bacterial vaginosis and cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Male circumcision for the prevention of HSV-2 and HPV infections and syphilis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Human papillomavirus and circumcision: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Male circumcision and women's risk of incident chlamydial, gonococcal, and trichomonal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Bacterial vaginosis is not associated with circumcision status of the current male partner

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Assessment of mucosal immunity to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

A highly efficient system to produce infectious human papillomavirus: Elucidation of natural virus-host interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

Male circumcision for prevention of heterosexual acquisition of HIV in men

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970190-0

7 January 2021

10.1016/S1473-3099(10)70190-0

Identifiers

DOI

1 reference

31 July 2017

1 reference